NOT KNOWN DETAILS ABOUT PEMBROLIZUMAB COST

Evaluation Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indicator: Together with chemotherapy, for that remedy of Grownup people with regionally recurrent unresectable or metastatic triple-unfavorable breast cancer that have not obtained prior chemotherapy for metastatic disease and whose tumours Categorical programmed cell Demise-